Evidence map›Paper›PMID 21553400›Full record

ArticleDrugs & aging2011

Understanding patient compliance and persistence with osteoporosis therapy.

Deborah T Gold

Abstract read
PubMed Publisher
In one paragraph

Article in Drugs & aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Benefit of Wearing an Activity Tracker in Sarcoidosis.Journal of personalized medicine · 2020
    Article
  3. Article
  4. Cost and consequences of noncompliance to oral bisphosphonate treatment.Journal of managed care & specialty pharmacy · 2015
    Article
  5. Article
  6. Adherence to therapies in patients with type 2 diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2013
    Article
  7. Article
  8. Bone care nurses and the evolution of the nurse's educational function: the Guardian Angel(®) research project.Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Deborah T GoldDuke University Medical Center, Durham, North Carolina, USA. dtg@geri.duke.edu
Duke Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic non-terminal diseases, including postmenopausal osteoporosis, are associated with poor treatment compliance and persistence. The longer a patient with osteoporosis complies and persists with treatment, the lower the risk of fracture. Retrospective studies with emphasis on real-world data have led to a greater understanding of the factors affecting medication compliance and persistence, and their association with improved treatment outcomes. However, these data do not contain information about patient choices of medication or patient commitment to particular medication regimens. Patient preferences can affect compliance and persistence behaviours. While recent evidence questions the importance of dosing regimen in patient preferences, other recent data show that medication efficacy and safety remain the most important determinants of patient preference. Informed patient decision making about treatment options, adverse effects and outcomes can have a beneficial impact on medication-taking behaviour. Healthcare professionals play a crucial role in the management of factors associated with poor compliance and persistence with osteoporosis therapies. Education about disease consequences and differences among treatment options, as well as treatment monitoring and positive reinforcement, are crucial to improving medication compliance and persistence in osteoporotic patients.

Indexed as

Patient ComplianceAgedDecision MakingDiphosphonatesDrug Administration ScheduleFemaleHumansMiddle AgedOsteoporosisOsteoporosis, PostmenopausalPatient SatisfactionPostmenopauseRetrospective StudiesTreatment OutcomeDiphosphonates

Identifiers

PMID21553400
OpenAlexW2054669633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.